KLOW Blend
Also known as: KLOW Stack, KLOW Protocol, Advanced Healing Blend
Key Facts: KLOW Blend
- Category
- Peptide Blend
- FDA Status
- Not FDA Approved
- Clinical Status
- Preclinical Research (Components)
- Administration
- Subcutaneous injection
- Typical Dose
- Standard vial dosing per protocol
- Frequency
- Once daily
- Evidence Level
- Animal Studies
- Duration
- 8-12 weeks
What to Expect
An advanced multi-peptide blend combining BPC-157 (10mg), TB-500 (10mg), GHK-Cu (50mg), and KPV (10mg) totaling 80mg per vial. Evolution of the Glow stack with added KPV for enhanced anti-inflammatory and gut health benefits.
Mechanism of Action
Combines the healing properties of BPC-157 and TB-500, the skin/tissue benefits of GHK-Cu, plus KPV's potent anti-inflammatory action via NF-κB inhibition. The addition of KPV makes this blend particularly effective for gut health and systemic inflammation.
Research Summary
KLOW builds on the Glow protocol by adding KPV, targeting deeper tissue repair and inflammatory conditions. The combination is popular for those with gut issues, autoimmune concerns, or chronic inflammation alongside healing and anti-aging goals.
Dosing Information
Note: Animal study doses may not translate directly to humans.
Typical Dosingⓘ
Community experience
Standard vial dosing per protocol
Varies by vendor formulation
Once daily
Advanced stack adding KPV for anti-inflammatory benefits. Good for gut health + healing + skin. Fasted for gut, evening for skin.
Research Dosingⓘ
Scientific studies
Advanced healing and anti-inflammatory blend
Doses from Studies
GHK-Cu 50mg, KPV 10mg, BPC-157 10mg, TB-500 10mg
Vendor Formulations - Standard KLOW formulation
Duration
8-12 weeks
Administration
Subcutaneous injection
Timing & Administration
Best Time to Take
Morning or evening
Once daily
Food Recommendation
With or without food
Why This Timing?
Can be used morning for gut benefits (fasted) or evening for skin repair
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Injection site reactions
- ●Mild fatigue initially
- ●Temporary GI changes (as gut heals)
- ●Headache (rare)
References
Related Peptides
Peptides commonly compared with KLOW Blend or used in similar applications.
Wolverine Stack
PreclinicalThe most popular healing peptide combination, combining BPC-157 (10mg) and TB-500 (10mg). Named after the Marvel character's regenerative abilities. Used for accelerated injury recovery, joint support, and tissue repair.
Peptide BlendGlow Protocol
PreclinicalA multi-peptide skin rejuvenation blend combining BPC-157 (5mg), TB-500 (10mg), and GHK-Cu (27mg). Designed for anti-aging, skin health, and tissue repair with a focus on collagen production and cellular regeneration.
Peptide BlendTB-500
Clinical TrialsA synthetic 17-amino acid fragment of Thymosin Beta-4 (TB-4). NOT the same as TB-4 - TB-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. Note: Many vendors mislabel TB-4 as 'TB-500' in premixed products.
HealingLL-37
Clinical TrialsA naturally occurring antimicrobial peptide and the only human cathelicidin. Part of the innate immune system with broad-spectrum antimicrobial activity.
ImmuneMatrixyl 3000
ResearchAn advanced version of Matrixyl combining two peptides for enhanced anti-aging effects. Targets both collagen production and inflammation.
Skin & HairBPC-157
PreclinicalA synthetic peptide derived from a protein found in human gastric juice. Known for its remarkable tissue healing properties across multiple body systems.
HealingWant updates on KLOW Blend research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.
Educational Information Only
This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.